Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma (Q37104779)
Jump to navigation
Jump to search
scientific article published on 15 December 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma |
scientific article published on 15 December 2008 |
Statements
1 reference
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma (English)
1 reference
Daphne A Haas-Kogan
1 reference
Michael D Prados
1 reference
David Stokoe
1 reference
Susan M Chang
1 reference
Nicholas Butowski
1 reference
Rebecca DeBoer
1 reference
Rupa Parvataneni
1 reference
Hannah Carliner
1 reference
Paul Kabuubi
1 reference
Jennifer Ayers-Ringler
1 reference
Jane Rabbitt
1 reference
Margaretta Page
1 reference
Anne Fedoroff
1 reference
Penny K Sneed
1 reference
Mitchel S Berger
1 reference
Michael W McDermott
1 reference
Andrew T Parsa
1 reference
Scott Vandenberg
1 reference
C David James
1 reference
Kathleen R Lamborn
1 reference
15 December 2008
1 reference
1 reference
579-584
1 reference
Identifiers
1 reference
1 reference
1 reference